- 2023 - 2026 Development and investigation of clinical utility of simple sensor device for novel urinary cancer biomarkers detection
- 2022 - 2025 Multifunctional nanoparticles for drug delivery and molecular imaging for pancreatic cancer
- 2021 - 2024 Development of cell signal-responsive contrast agent for diagnosis of NASH
- 2021 - 2024 Measurement of molecular pathogenesis of pancreatic cancer using cell function detection MRI contrast agents
- 2019 - 2022 Development of a novel diagnostic method for urothelial carcinoma targeting urinary activated protein kinase C-alpha
- 2019 - 2022 Ultrasensitive MRI detection of spontaneous pancreatic tumors with nanocage-based targeted contrast agent
- 2018 - 2021 Nano-sized MRI contrast agents for ultra-sensitive imaging of tumor microenvironment
- 2018 - 2020 In vivo imaging of inflammasome activation for clinical diagnosis
- 2015 - 2018 Medical imaging of pancreatic tumors with nanocage-based targeted contrast agent
- 2015 - 2018 Biodegradable nano-cages for controlled drug release
- 2015 - 2018 Ultrasensitive MRI detection of spontaneous pancreatic tumors with nanocage-based targeted contrast agent
- 2013 - 2015 Development and medical application of nano-sized MRI contrast agents using protein nanocages
- 2012 - 2015 Protein Nanocages-Conjugated Magnetic Resonance Contrast Agents Displaying High Relaxivity and Tumor Selectivity.
- 2013 - 2014 Pancreatic cancer specific targeting by protein nanocages
- 2011 - 2012 Biological evaluation of protein nanocapsules containing doxorubicin
Show all